tradingkey.logo
tradingkey.logo
Search

Unicycive Therapeutics Inc

UNCY
Add to Watchlist
4.820USD
+0.010+0.21%
Market hours 09/24, 15:20(ET)
128.69MMarket Cap
LossP/E TTM

UNCY Financials

See Unicycive Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
128.69M
Dividend TTM
0.00
P/E TTM
-2.14
EPS TTM
-2.25
Revenue
--
Net Profit
-37.82M
ROE
-162.89%
ROA
-86.51%

Unicycive Therapeutics Inc Earnings Date

Latest Release
Aug 12, 2026
EPS / Forecast
-0.06/-0.34
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
87.79%-0.06
-1327.32%-0.54
66.38%-0.68
27.74%-0.33
-165.30%-0.52
100.72%0.04
8.99%-2.04
65.89%-0.46
127.53%0.80
37.45%-6.06
36.69%-2.24
---1.35
---2.92
---9.69
---3.53
---0.85
----
----
----
----
Revenue
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
-100.00%0.00
--0.00
--675.00K
--0.00
--951.00K
----
----
----
----
Net Profit
73.29%-1.72M
-2614.31%-12.82M
31.86%-14.67M
-46.75%-6.01M
-311.86%-6.45M
102.41%510.00K
-176.03%-21.52M
7.01%-4.10M
168.52%3.04M
-43.37%-21.17M
-46.36%-7.80M
20.73%-4.41M
-22.14%-4.44M
-317.50%-14.77M
-93.60%-5.33M
-6.84%-5.56M
-230.55%-3.64M
-266.91%-3.54M
-212.73%-2.75M
-640.88%-5.20M
Net Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
---2159.26%
----
---1338.59%
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
--100.00%
----
--100.00%
----
----
----
----
Revenue
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
-100.00%0.00
--0.00
--675.00K
--0.00
--951.00K
----
----
----
----
Operating profit
-45.63%-10.14M
-5.61%-8.44M
22.00%-7.22M
-17.45%-7.34M
5.92%-6.96M
13.20%-7.99M
-46.70%-9.26M
-5.27%-6.25M
-71.24%-7.40M
-119.04%-9.20M
-18.55%-6.31M
-6.91%-5.94M
-18.87%-4.32M
-18.80%-4.20M
-93.50%-5.33M
-17.79%-5.55M
-366.75%-3.64M
-383.86%-3.54M
-283.82%-2.75M
-654.40%-4.71M
Net Profit
73.29%-1.72M
-2614.31%-12.82M
31.86%-14.67M
-46.75%-6.01M
-311.86%-6.45M
102.41%510.00K
-176.03%-21.52M
7.01%-4.10M
168.52%3.04M
-43.37%-21.17M
-46.36%-7.80M
20.73%-4.41M
-22.14%-4.44M
-317.50%-14.77M
-93.60%-5.33M
-6.84%-5.56M
-230.55%-3.64M
-266.91%-3.54M
-212.73%-2.75M
-640.88%-5.20M
Current assets
141.55%71.32M
132.37%63.55M
58.20%48.96M
33.24%50.29M
-32.98%29.53M
-47.08%27.35M
130.97%30.95M
103.25%37.74M
100.88%44.05M
97.36%51.68M
406.77%13.40M
86.40%18.57M
74.60%21.93M
69.32%26.18M
-85.64%2.64M
-49.64%9.96M
1275.68%12.56M
2914.42%15.46M
8925.00%18.41M
8932.88%19.78M
Total current liabilities
37.87%18.70M
58.82%26.48M
-21.48%18.94M
25.55%13.13M
3.67%13.57M
-44.93%16.68M
37.56%24.12M
-32.33%10.46M
-15.13%13.09M
89.62%30.28M
433.92%17.53M
179.90%15.46M
444.07%15.42M
564.86%15.97M
56.01%3.28M
603.44%5.52M
-44.59%2.83M
-38.65%2.40M
-26.78%2.10M
-62.26%785.00K
Total assets
140.14%72.03M
130.46%64.41M
55.16%49.13M
31.20%50.61M
-32.90%30.00M
-46.65%27.95M
123.16%31.67M
98.41%38.57M
95.35%44.70M
92.58%52.38M
403.58%14.19M
91.04%19.44M
78.55%22.88M
72.60%27.20M
-84.97%2.82M
-48.55%10.18M
1303.72%12.82M
2972.12%15.76M
9088.24%18.74M
8932.88%19.78M
Total liabilities
38.28%18.76M
60.12%26.70M
-21.86%18.94M
22.44%13.13M
1.54%13.57M
-45.60%16.68M
34.65%24.24M
-33.01%10.72M
-16.78%13.36M
83.72%30.65M
448.11%18.00M
188.38%16.01M
452.41%16.05M
563.16%16.68M
45.31%3.28M
607.13%5.55M
-43.19%2.91M
-35.73%2.52M
-21.39%2.26M
-62.26%785.00K
Total equity
224.24%53.27M
234.52%37.70M
306.37%30.20M
34.58%37.48M
-47.58%16.43M
-48.13%11.27M
295.09%7.43M
711.01%27.85M
358.87%31.34M
106.63%21.73M
-717.38%-3.81M
-25.77%3.43M
-31.08%6.83M
-20.59%10.52M
-102.83%-466.00K
-75.65%4.63M
335.84%9.91M
489.30%13.24M
717.15%16.48M
1120.80%19.00M
Net operating income
9.69%-7.60M
29.90%-6.24M
-22.66%-8.03M
35.56%-5.96M
-33.25%-8.42M
-37.90%-8.90M
-47.51%-6.55M
-109.23%-9.25M
-14.85%-6.32M
-64.69%-6.46M
27.04%-4.44M
-24.11%-4.42M
-80.57%-5.50M
-32.57%-3.92M
-333.64%-6.08M
-2.56%-3.56M
-1304.15%-3.05M
-339.38%-2.96M
-160.78%-1.40M
-392.07%-3.47M
Net investment
-283.33%-23.00K
-32118.75%-5.16M
-54768.18%-12.07M
91.67%-2.00K
70.00%-6.00K
-166.67%-16.00K
---22.00K
---24.00K
-66.67%-20.00K
---6.00K
--0.00
--0.00
---12.00K
100.00%0.00
100.00%0.00
--0.00
--0.00
---2.00K
---29.00K
----
Net financing
31.47%14.44M
668.62%19.57M
1709.86%6.61M
16871.97%26.33M
1454.38%10.98M
-94.43%2.55M
278.05%365.00K
-207.84%-157.00K
---811.00K
64.37%45.69M
56.48%-205.00K
---51.00K
--0.00
--27.80M
---471.00K
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
2697.40%21.48M

FAQs

What are the current assets of Unicycive Therapeutics Inc?

According to Unicycive Therapeutics Inc's FY2025 earnings report, its current assets were 48.96M, with a year-on-year change of 58.20.

What are the total assets of Unicycive Therapeutics Inc?

According to Unicycive Therapeutics Inc's FY2025 earnings report, its total assets of Unicycive Therapeutics Inc were 49.13M, with a year-on-year change of 55.16.

What are the total liabilities of Unicycive Therapeutics Inc?

According to Unicycive Therapeutics Inc's FY2025 earnings report, its total liabilities of Unicycive Therapeutics Inc were 18.94M, with a year-on-year change of -21.86.

What is the total equity of Unicycive Therapeutics Inc?

According to Unicycive Therapeutics Inc's FY2025 earnings report, its total equity of Unicycive Therapeutics Inc was 30.20M, with a year-on-year change of 306.37.

What is the net operating income of Unicycive Therapeutics Inc?

According to Unicycive Therapeutics Inc's FY2025 earnings report, its net operating income of Unicycive Therapeutics Inc was -29.52M, with a year-on-year change of 8.10.

What is the net investment of Unicycive Therapeutics Inc?

According to Unicycive Therapeutics Inc's FY2025 earnings report, its net investment of Unicycive Therapeutics Inc was -12.10M, with a year-on-year change of -16698.61.

What is the net financing of Unicycive Therapeutics Inc?

According to Unicycive Therapeutics Inc's FY2025 earnings report, its net financing of Unicycive Therapeutics Inc was 46.47M, with a year-on-year change of 3.06.

What is the Earnings Per Share (EPS) of Unicycive Therapeutics Inc?

According to Unicycive Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.67, with a year-on-year change of 70.40.

What is the net income of Unicycive Therapeutics Inc?

According to Unicycive Therapeutics Inc's FY2025 earnings report, its net income was -26.55M, with a year-on-year change of 29.79.

What is the Return on Equity (ROE) of Unicycive Therapeutics Inc?

According to Unicycive Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -141.14, with a year-on-year change of 93.24.

What is the Return on Assets (ROA) of Unicycive Therapeutics Inc?

According to Unicycive Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -65.73, with a year-on-year change of 58.97.

What is the operating profit of Unicycive Therapeutics Inc?

According to Unicycive Therapeutics Inc's FY2025 earnings report, its operating profit was -29.52M, with a year-on-year change of 8.10.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.